Skip to main content
. 2017 Jun;139(6):1830–1839.e13. doi: 10.1016/j.jaci.2016.09.024

Table E1.

Verification of participant blinding

Patient guess trial arm Trial arm
Control subjects (n = 43) Subjects receiving intradermal immunotherapy (n = 44)
Intradermal immunotherapy (n = 44) 22 22
Control (n = 43) 21 22

At the end of the pollen season, participants verified blinding by guessing whether they had received active or control treatment.